EW

Edwards Lifesciences Corporation

Healthcare
87.66 -0.50 -0.57% Market Closed
2026-06-02 • USD

Key Metrics

Market Cap 50.47B
EV —
Shares Out 575.80M
Revenue (ttm) 6.30B
Net Income 1.10B
Beta —
P/E 46.39
Forward P/E —
EPS (ttm) $1.88
P/S —
P/B 4.92
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 8.23%
ROE 10.47%
ROIC —
Gross Margin 77.87%
Oper. Margin 21.37%
Profit Margin 17.39%
Debt/Eq 0.07
LT Debt/Eq 5.48%
Quick Ratio —
Current Ratio 4.42
Book/sh 17.83
Cash/sh 4.22
Div Yield —
Div TTM —
Payout Ratio —
SMA20 5.07%
SMA50 6.95%
SMA200 7.42%
Volume 3,807,720
Avg Volume 5.01M
Rel Volume —
Perf Week 1.38%
Perf Month 5.73%
Perf Quarter 4.49%
Perf Half Y 1.71%
Perf YTD 2.83%
Perf Year 12.72%
Perf 3Y 2.00%
Perf 5Y -8.56%

Factor Lens

Seasonal Performance

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Edwards Lifesciences Corporation is the leading global structural heart innovation company driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence, and partnerships with clinicians and healthcare stakeholders, the company delivers life-changing innovations to those who need them most. The company specializes in transcatheter aortic valve replacement (TAVR) therapies, transcatheter mitral and tricuspid (TMTT) therapies, and surgical heart valve solutions. Edwards operates across multiple geographic segments including the United States, Europe, Japan, and Rest of World. The company's portfolio includes advanced products such as SAPIEN valves, PASCAL repair systems, and RESILIA tissue technology. In 2025, Edwards achieved sales of $6.1 billion, up 11.5% year-over-year on an underlying basis, and invested more than $1 billion in research and development to advance pipelines in TAVR, TMTT, and Surgical structural heart therapies, while building emerging opportunities in structural heart failure and aortic regurgitation.

Name
Edwards Lifesciences Corporation
Industry
Medical Instruments & Supplies
CEO
Bernard Zovighian · Chief Executive Officer
Employees
16,000 as of 2025-12-31
IPO Date
2018-12-18
Phone
(949) 250-2500
Address
One Edwards Way, Irvine, CA 92614
Website
www.edwards.com

Key Executives

Name Title FY Pay
Bernard Zovighian Chief Executive Officer —

Latest News